Taking everything into account, ADMA scores 7 out of 10 in our fundamental rating. ADMA was compared to 525 industry peers in the Biotechnology industry. ADMA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. ADMA is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make ADMA a good candidate for growth investing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 36.83% | ||
| ROE | 48.57% | ||
| ROIC | 25.76% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 34.19% | ||
| PM (TTM) | 42.87% | ||
| GM | 54.71% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 1.78 | ||
| Altman-Z | 20.07 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.13 | ||
| Quick Ratio | 3.65 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.22 | ||
| Fwd PE | 19.06 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 101.98 | ||
| EV/EBITDA | 23.67 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ChartMill assigns a fundamental rating of 7 / 10 to ADMA.
ChartMill assigns a valuation rating of 6 / 10 to ADMA BIOLOGICS INC (ADMA). This can be considered as Fairly Valued.
ADMA BIOLOGICS INC (ADMA) has a profitability rating of 6 / 10.
The financial health rating of ADMA BIOLOGICS INC (ADMA) is 8 / 10.